<DOC>
	<DOCNO>NCT00735683</DOCNO>
	<brief_summary>This primary purpose study determine ATHX-105 phosphate cause weight loss 12-week period .</brief_summary>
	<brief_title>A Short-Term Study Examine Effects ATHX-105 Phosphate Weight Loss Safety</brief_title>
	<detailed_description>The rate obesity adult continue increase . Obesity affect overall health associate increase risk diabetes , high blood pressure , coronary artery disease , osteoarthritis , sleep apnea . To date , medication option treat obesity limit . This study examine new investigational drug , ATHX-105 phosphate , may cause weight loss human 12-week period .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Obese adult body mass index 3045 kg/m2 Pregnancy Diabetes Adults serious unstable current past medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Weight loss</keyword>
	<keyword>Weight-loss drug</keyword>
	<keyword>Obesity</keyword>
	<keyword>Overweight</keyword>
	<keyword>Body weight</keyword>
	<keyword>Diet</keyword>
	<keyword>Metabolic Disorder</keyword>
	<keyword>Nutrition Disorder</keyword>
</DOC>